The company's financial position is increasingly vulnerable, with cash reserves declining from $28.5 million in 2023Q4 to $4.3 million in 2026Q1 while accumulated deficits reached $140.3 million.
| Total Current Assets | 31.67M | 34.51M | 42.78M | 45.66M | 61.14M | 101.2M | 16.41M | 15.42M |
| Cash & Short-Term Investments | 4.31M | 5.91M | 30.4M | 28.48M | 42.24M | 87.52M | 5.13M | 9.68M |
| Cash Only | 4.31M | 5.91M | 3.71M | 28.48M | 42.24M | 87.52M | 3.31M | 4.14M |
| Short-Term Investments | 0 | 0 | 26.69M | 0 | 0 | 0 | 1.81M | 5.53M |
| Accounts Receivable | 5.67M | 4.62M | 4.31M | 3.95M | 4.28M | 5.85M | 6.57M | 2.99M |
| Days Sales Outstanding | 44.89 | 41.6 | 41.7 | 39.28 | 37.74 | 57.92 | 76.61 | 54.24 |
| Inventory | 6.87M | 7.05M | 6.8M | 11.59M | 12.25M | 5.39M | 3.58M | 2.57M |
| Days Inventory Outstanding | 94.12 | 95.08 | 81.35 | 160.37 | 186.69 | 102.16 | 96.55 | 81.3 |
| Other Current Assets | 14.82M | 16.93M | 1.27M | 1.63M | 0 | 0 | 1.14M | 0 |
| Total Non-Current Assets | 66.98M | 69.07M | 75.99M | 82.93M | 91.12M | 65.31M | 46.5M | 43.09M |
| Property, Plant & Equipment | 54.13M | 55.84M | 61.52M | 66.84M | 71.31M | 29.81M | 10.01M | 5.45M |
| Fixed Asset Turnover | 0.74x | 0.73x | 0.61x | 0.55x | 0.58x | 1.24x | 3.13x | 3.69x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 16.61M | 16.61M | 16.61M |
| Intangible Assets | 11.66M | 11.94M | 13.09M | 14.24M | 17.56M | 18.7M | 19.85M | 21M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.2M | 1.28M | 1.38M | 1.85M | 2.25M | 180K | 24K | 32K |
| Total Assets | 98.66M | 103.58M | 118.77M | 128.59M | 152.26M | 166.51M | 62.91M | 58.51M |
| Asset Turnover | 0.40x | 0.39x | 0.32x | 0.29x | 0.27x | 0.22x | 0.50x | 0.34x |
| Asset Growth % | -43.73% | -12.79% | -7.64% | -15.55% | -8.56% | 164.68% | 7.52% | - |
| Total Current Liabilities | 6.9M | 7.54M | 11.21M | 8.88M | 10.88M | 7.74M | 3.96M | 5.58M |
| Accounts Payable | 1.62M | 1.38M | 825K | 1.49M | 2.45M | 2.25M | 1.64M | 768K |
| Days Payables Outstanding | 17.48 | 18.57 | 9.87 | 20.65 | 37.33 | 42.58 | 44.07 | 24.33 |
| Short-Term Debt | 1.92M | 1.88M | 4.04M | 0 | 0 | 0 | 0 | 45K |
| Deferred Revenue (Current) | 5K | 0 | 30K | 16K | 198K | 200K | 0 | 0 |
| Other Current Liabilities | 3.36M | 4.28M | 0 | 0 | 0 | 0 | 845K | 0 |
| Current Ratio | 4.59x | 4.58x | 3.82x | 5.14x | 5.62x | 13.07x | 4.14x | 2.76x |
| Quick Ratio | 3.60x | 3.64x | 3.21x | 3.84x | 4.50x | 12.37x | 3.24x | 2.30x |
| Cash Conversion Cycle | 121.53 | 118.11 | 113.18 | 179 | 187.1 | 117.5 | 129.09 | 111.21 |
| Total Non-Current Liabilities | 26.84M | 27.27M | 25.16M | 29.68M | 41.5M | 15.56M | 6.54M | 40.02M |
| Long-Term Debt | 12.74M | 13.27M | 9.44M | 13.25M | 21.98M | 11.87M | 0 | 0 |
| Capital Lease Obligations | 14.05M | 0 | 14.88M | 15.4M | 18.11M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 3.62M | 879K | 827K | 919K | 1.22M | 3.15M | 5.99M | 3.9M |
| Other Non-Current Liabilities | 13.17M | 13.12M | 10K | 102K | 191K | 542K | 554K | 36.12M |
| Total Liabilities | 33.73M | 34.81M | 36.38M | 38.55M | 52.38M | 23.31M | 10.51M | 45.6M |
| Total Debt | 14.66M | 15.15M | 30.17M | 30.46M | 42.31M | 11.87M | 0 | 45K |
| Net Debt | 10.35M | 9.23M | 26.46M | 1.97M | 74K | -75.65M | -3.31M | -4.1M |
| Debt / Equity | 0.23x | 0.22x | 0.37x | 0.34x | 0.42x | 0.08x | - | 0.00x |
| Debt / EBITDA | -1.47x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -1.04x | - | - | - | - | - | -0.49x | - |
| Interest Coverage | -20.78x | -23.23x | -38.06x | -37.45x | - | -20.39x | - | - |
| Total Equity | 64.92M | 68.78M | 82.39M | 90.04M | 99.89M | 143.2M | 52.41M | 12.91M |
| Equity Growth % | -54.32% | -16.53% | -8.49% | -9.86% | -30.25% | 173.26% | 305.93% | - |
| Book Value per Share | 1.21 | 1.29 | 1.76 | 2.83 | 3.56 | 5.11 | 13.18 | 3.55 |
| Total Shareholders' Equity | 64.92M | 68.78M | 82.39M | 90.04M | 99.89M | 143.2M | 52.41M | 12.91M |
| Common Stock | 1K | 1K | 1K | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -140.34M | -135.79M | -118.53M | -91.79M | -55.01M | -7.54M | 2.27M | -1.3M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 7K | 20K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Imminent liquidity and dilution
As reported in recent financial filings, Alpha Teknova's total assets have declined from $128.6 million in 2023Q4 to $98.7 million in 2026Q1, a trend that underscores the ongoing consumption of capital to fund persistent operating deficits and facility-related overhead requirements.
The consistent contraction of the asset base suggests that the company is struggling to maintain its operational footprint while absorbing significant net losses. This downward trajectory in total assets, coupled with the lack of meaningful revenue growth, implies that the firm's current business model is not yet self-sustaining.
Based on the company's reported figures, cash and equivalents have plummeted from $28.5 million in 2023Q4 to just $4.3 million as of 2026Q1, signaling a critical liquidity inflection point that warrants immediate investor attention regarding potential future financing needs.
The rapid depletion of cash reserves relative to the company's ongoing operating burn rate suggests that the current liquidity buffer is insufficient to support long-term operations without external intervention. Investors should monitor the potential for dilutive equity issuance, as the current cash position provides very little margin for error.
According to the balance sheet data, net property, plant, and equipment (PPE) remains the dominant asset component at $54.1 million, representing over 50% of total assets, which highlights the company's heavy reliance on its Hollister facility to drive future production capacity.
This asset-heavy structure creates significant operating leverage that currently acts as a drag on profitability due to underutilization. The concentration in fixed assets suggests that the company's ability to pivot or scale down is limited, leaving it highly exposed to fluctuations in biotech R&D spending.
As indicated in the latest quarterly reports, the company's retained earnings have deteriorated to a deficit of $140.3 million, reflecting a sustained period of value destruction that continues to weigh heavily on the overall equity position of the firm.
The persistent growth of the accumulated deficit suggests that the company has yet to find a path to profitability, effectively consuming shareholder capital to fund its operational ramp-up. This trend may complicate future capital raising efforts, as the market typically demands a clearer line of sight to positive earnings.
Quick answers to the most common questions about buying TKNO stock.
As of 2025, Alpha Teknova, Inc. (TKNO) had total assets of $103.6M including $34.5M in current assets.
Alpha Teknova, Inc. (TKNO) carries total debt of $15.1M, offset by $5.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Alpha Teknova, Inc. (TKNO) has total shareholders' equity (book value) of $68.8M ($1.29 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Alpha Teknova, Inc. (TKNO) reported a current ratio of 4.58x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.